Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $492.97 ($4.7M) on 2026-09-21, disclosed to the SEC on 2026-09-22.
Scheduled sale ($4.7M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $492.97 | 1,520 | $749K | 15.9% |
| 2 | $493.60 | 2,680 | $1.3M | 28.2% |
| 3 | $494.82 | 2,170 | $1.1M | 22.9% |
| 4 | $495.71 | 2,287 | $1.1M | 24.1% |
| 5 | $496.62 | 843 | $419K | 8.9% |
| Total | $494.55 avg | 9,500 |
| $4.7M |
| 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |